6[1]Josse D, Mdasson P. Human plasma paraoxonase. Ann Pham Fr, 2001, 59(2): 108～118.
7[2]Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidised low density lipoprotein. J Clin Invest, 1996: 2882～2891.
8[5]Aviram M, Hardak E, Vaya J, et al. Human serum paraoxonase(PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions. Circulation, 2000,101: 2510～2517.
9[6]Senti M, Tomas M, Marrugat J, et al. Paraoxonase 1192 polymorphism modilates the nonfatal myocardial infarction risk associated with decreases HDLs. Arterioscler Thromb Vasc Biol,2001, 21: 415～420.
10BORGGREVE S E, de VRIES R, DULLAART R P. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid tra
